Thats a tricky question, because it depends on what exactly youre asking
In a 56-day phase-2 trial, 9 participants with severe dry eye syndrome were treated with synthetic TB4 eye drops or placebo for 28 days, followed by a 28-day observational period
What changed on April 30, 2026: The FDA announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B compounding bulks list
In a double-blind crossover trial, patients with confirmed fructose malabsorption who took XI with a fructose load had lower hydrogen breath levels and fewer GI symptoms than on placebo, suggesting it may help those who experience discomfort from consuming apples, pears, honey, or high-fructose sweeteners.4 People taking GLP-1 medications (Ozempic, Wegovy, Mounjaro, etc.) GLP-1 receptor agonists commonly slow stomach emptying and cause nausea, fullness, and constipation
Ex-4 offered protection against MCAO-induced disorder of the cerebral blood flow (CBF), expression of reactive oxygen species (ROS) in the blood and brain, production of oxidative stress-related and inflammatory proteins, dyskinesia and cognitive dysfunction, and contraction of the bladder in mouse with diabetes (99)
Ozempic [package insert]